(Q40923101)

24 September 2017

1 reference

title

Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections (English)

1 reference

24 September 2017

C M Perry

1

1 reference

24 September 2017

A J Wagstaff

series ordinal

2

1 reference

24 September 2017

publication date

1 August 1995

1 reference

24 September 2017

1 reference

24 September 2017

volume

50

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

396-415

1 reference

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

24 September 2017

cites work

1 reference

12 December 2020

The role of oral acyclovir in the management of genital herpes simplex

1 reference

12 December 2020

Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.

1 reference

12 December 2020

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

12 December 2020

Recognition and treatment of shingles

1 reference

12 December 2020

Lack of effect of acyclovir on postherpetic neuralgia

1 reference

12 December 2020

Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.

1 reference

12 December 2020

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster

1 reference

12 December 2020

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

12 December 2020

Pharmacokinetics of famciclovir in subjects with varying degrees of renal impairment

1 reference

12 December 2020

Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model

1 reference

12 December 2020

Metabolic and pharmacokinetic studies following oral administration of 14C-famciclovir to healthy subjects

1 reference

12 December 2020

Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteers

1 reference

12 December 2020

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

1 reference

12 December 2020

Safety of famciclovir in patients with herpes zoster and genital herpes

1 reference

12 December 2020

Current experience with antiviral therapy for acute herpes zoster

1 reference

12 December 2020

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

12 December 2020

Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells

1 reference

12 December 2020

In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2

1 reference

12 December 2020

Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers

1 reference

12 December 2020

Prodrugs of the selective antiherpesvirus agent 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine (BRL 39123) with improved gastrointestinal absorption properties

1 reference

12 December 2020

10.2165/00003495-199550020-00011

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1011521600

0 references

Fatcat ID

release_app2wfb27ncytfzm3rxo3qyzau

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/app2wfb27ncytfzm3rxo3qyzau

24 November 2022

mapped directly with Wikidata item

1 reference